Academic Bibliography

Search 200 years of publications by Ghent University researchers.

prof. dr. apr. Evelien Wynendaele

Faculty of Pharmaceutical Sciences > Department of Pharmaceutical analysis

ORCID iD: 0000-0003-0969-7580

Add to list
- Conference Paper
- C3
- open access
Quorum sensing peptides in sarcopenia : insights from iAM373

Liesbeth Crombez (UGent) , sumaira jabeen (UGent) , Petar Naumovski (UGent) , Nele Van Den Noortgate (UGent) , Bart De Spiegeleer (UGent) , Evelien Wynendaele (UGent) and Anton De Spiegeleer (UGent)

(2026) JCSM COMMUNICATIONS. In JCSM Communications 9(1).
Add to list
Structure-function relationship of methacryloyl-modified gelatin revealed by proteomics and 3D modeling

Laurens Parmentier (UGent) , Fabrice Bray, Joeri Van Meerssche (UGent) , Tom Gheysens (UGent) , Evelien Wynendaele (UGent) , Christian Rolando, Sandra Van Vlierberghe (UGent) and Nele Pien (UGent)

(2026) APPLIED MATERIALS TODAY. 48.
Add to list
Implementation of blood flow restriction training in the acute geriatric unit

Raoul De Smet (UGent) , Astrid Brys (UGent) , Patrick Calders (UGent) , Evelien Wynendaele (UGent) , Nele Van Den Noortgate (UGent) and Anton De Spiegeleer (UGent)

(2025) AGE AND AGEING. 54(10).
Add to list
- Journal Article
- A1
- open access
Role of peptides in skeletal muscle wasting : a scoping review

Petar Naumovski (UGent) , Bart De Spiegeleer (UGent) , Aster Wakjira Garedo (UGent) , Christophe Van De Wiele (UGent) , Vincent Mouly, Katarzyna Goljanek‐Whysall, Kauê Santana da Costa, Ewerton Cristhian Lima de Oliveira, Evelien Wynendaele (UGent) and Anton De Spiegeleer (UGent)

(2025) JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE. 16(6).
Add to list
- Journal Article
- A1
- open access
Beyond molecular weight : peptide characteristics influencing the sensitivity of retention to changes in organic solvent in reversed-phase chromatography

Amélie Descamps (UGent) , Hannah Hirmz (UGent) , Ewerton de Oliveira, Anton De Spiegeleer (UGent) , Juliana Feio, Kaue da Costa, Bart De Spiegeleer (UGent) and Evelien Wynendaele (UGent)

(2025) ACS OMEGA. 10(25). p.27089-27097
Add to list
Sustainability of drug discovery, development and use as embedded in European pharmaceutical policies

Bart De Spiegeleer (UGent) and Evelien Wynendaele (UGent)

(2025) CURRENT OPINION IN GREEN AND SUSTAINABLE CHEMISTRY. 53.
Add to list
- Journal Article
- A2
- open access
Sample preparation in analytical peptidomics : it's all about timing

Amélie Descamps (UGent) , Bart De Spiegeleer (UGent) , Evelien Wynendaele (UGent) , Petar Naumovski (UGent) and Anton De Spiegeleer (UGent)

(2025) TALANTA OPEN. 11.
Add to list
- Journal Article
- A1
- open access
Photopharmacological activation of adenosine A1 receptor signaling suppresses seizures in a mouse model for temporal lobe epilepsy

Jeroen Spanoghe (UGent) , Evelien Wynendaele (UGent) , Marijke Vergaelen (UGent) , Maren De Colvenaer (UGent) , Tina Mariman, Kristl Vonck (UGent) , Evelien Carrette (UGent) , Wytse Wadman (UGent) , Erine Craey, Lars Emil Larsen (UGent) , et al.

(2025) JOURNAL OF CONTROLLED RELEASE. 381.
Add to list
- Journal Article
- A1
- open access
The association between statins and gait speed reserve in older adults : effects of concomitant medication

Anton De Spiegeleer (UGent) , Antoon Bronselaer (UGent) , Ine Mahieu, Dorien Vreys, Aaron Haslbauer, Jan-Philipp Leibfarth, Lara Van Schoote, Aster Wakjira Garedo (UGent) , Mirko Petrovic (UGent) , Evelien Wynendaele (UGent) , et al.

(2025) GEROSCIENCE.
Add to list
- Book Chapter
Geneesmiddelenontwikkeling en AI : rollen de moleculen nu gewoon uit de computer?

Evelien Wynendaele (UGent) , Hannah Hirmz (UGent) and Bart De Spiegeleer (UGent)

(2024) Geneeskunde in tijden van AI : handvatten voor vandaag en morgen. p.161-179

1
2
3
4
…
18
19

Next →